Clinical Trial Site is a clinical research site located in Chicago, Illinois, United States 60611.
Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
Clinical Trial Site has participated in 43 clinical trials with 14 currently active.
Therapeutic areas: Atypical Hemolytic Uremic Syndrome, Wilson Disease, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy.
Sponsors: Alexion Pharmaceuticals, Inc., Alnylam Pharmaceuticals, AMAG Pharmaceuticals, Inc..
Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Clinical Trial Site has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Clinical Trial Site has 43 clinical trials on record, with 14 currently active. Their work covers Atypical Hemolytic Uremic Syndrome, Wilson Disease, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy.
Yes — Clinical Trial Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.